Subscribe in a reader

Cambridge MedChem Consulting

New approaches to the treatment of Parkinson’s

The website the the RSC-BMCS conference on New approaches to the treatment of Parkinson’s is now live! Details are on the website including registration details.

https://www.rscbmcs.org/events/parkinsons25/

In the dynamic field of drug discovery, the search for new treatments for Parkinson’s disease has never been more critical. It is estimated 10 million people worldwide are living with Parkinson’s – a chronic, progressive neurodegenerative condition resulting from the loss of the dopamine-containing cells of the substantia nigra. Motor and non-motor symptoms of the condition are wide ranging and current treatments only help to manage a small subset of the symptoms and do not modify the disease progression. But there is a wealth of research to find new and better therapeutics for Parkinson’s.

This meeting, specifically designed for professionals dedicated to developing new therapeutics for Parkinson’s disease, will highlight current research offering symptomatic relief and disease modifying approaches.

Abstract submissions for Oral and posters are now open and the submission for is here.

https://www.rscbmcs.org/wp-content/uploads/2024/10/Abstract-form.pdf, please send the completed forms to events@hg3.co.uk.

Sponsorship and Exhibition opportunities are detailed on the website.